Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Endothelin antagonists discovered at Ajinomoto

April 22, 1998

Cell proliferation inhibitors developed at Roche

April 22, 1998

More retinoids emerge from the Allergan pipeline

April 21, 1998

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

April 21, 1998

New water-soluble dolastatin derivatives with potent antitumor activity

April 21, 1998

Heterocyclic tachykinin antagonists from Sanofi

April 21, 1998

MS&D discovers agents for safely enhancing cognition

April 21, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

April 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...